Halyard Health Inc. (HYH) Reaches New 1-Year High at $37.31
Halyard Health Inc. (NYSE:HYH) reached a new 52-week high during mid-day trading on Monday . The company traded as high as $37.31 and last traded at $37.22, with a volume of 265,439 shares trading hands. The stock had previously closed at $36.11.
A number of equities research analysts have issued reports on HYH shares. Zacks Investment Research upgraded shares of Halyard Health from a “hold” rating to a “buy” rating and set a $33.00 price target for the company in a report on Friday, May 6th. Stifel Nicolaus upped their price target on shares of Halyard Health from $32.00 to $37.00 and gave the company a “buy” rating in a report on Tuesday, June 14th. Deutsche Bank AG upped their price target on shares of Halyard Health from $36.00 to $41.00 and gave the company a “buy” rating in a report on Wednesday, August 10th. Finally, TheStreet upgraded shares of Halyard Health from a “sell” rating to a “hold” rating in a report on Friday, July 8th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the company. Halyard Health has an average rating of “Buy” and a consensus price target of $34.20.
The firm’s 50 day moving average is $34.89 and its 200-day moving average is $30.74. The company’s market capitalization is $1.71 billion.
Halyard Health (NYSE:HYH) last issued its quarterly earnings results on Wednesday, August 3rd. The company reported $0.45 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.36 by $0.09. During the same period last year, the company posted $0.52 EPS. The firm had revenue of $400 million for the quarter, compared to the consensus estimate of $383.08 million. The business’s revenue was up 2.7% on a year-over-year basis. On average, equities analysts forecast that Halyard Health Inc. will post $1.82 EPS for the current year.
A number of institutional investors recently added to or reduced their stakes in the company. First Trust Advisors LP bought a new position in Halyard Health during the fourth quarter worth about $1,234,000. Mutual of America Capital Management LLC boosted its position in Halyard Health by 2.8% in the fourth quarter. Mutual of America Capital Management LLC now owns 32,002 shares of the company’s stock worth $1,069,000 after buying an additional 868 shares in the last quarter. Cornerstone Capital Management Holdings LLC. bought a new position in Halyard Health during the fourth quarter worth about $1,454,000. Wells Fargo & Company MN boosted its position in Halyard Health by 73.8% in the fourth quarter. Wells Fargo & Company MN now owns 581,871 shares of the company’s stock worth $19,440,000 after buying an additional 247,075 shares in the last quarter. Finally, BlackRock Advisors LLC boosted its position in Halyard Health by 151.2% in the fourth quarter. BlackRock Advisors LLC now owns 533,462 shares of the company’s stock worth $17,823,000 after buying an additional 321,059 shares in the last quarter.
Halyard Health, Inc seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.